1. Home
  2. BLCO vs POST Comparison

BLCO vs POST Comparison

Compare BLCO & POST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLCO
  • POST
  • Stock Information
  • Founded
  • BLCO 1853
  • POST 1895
  • Country
  • BLCO Canada
  • POST United States
  • Employees
  • BLCO N/A
  • POST N/A
  • Industry
  • BLCO Ophthalmic Goods
  • POST Packaged Foods
  • Sector
  • BLCO Health Care
  • POST Consumer Staples
  • Exchange
  • BLCO Nasdaq
  • POST Nasdaq
  • Market Cap
  • BLCO 5.2B
  • POST 5.9B
  • IPO Year
  • BLCO 2022
  • POST N/A
  • Fundamental
  • Price
  • BLCO $14.97
  • POST $106.18
  • Analyst Decision
  • BLCO Hold
  • POST Buy
  • Analyst Count
  • BLCO 12
  • POST 5
  • Target Price
  • BLCO $15.91
  • POST $130.80
  • AVG Volume (30 Days)
  • BLCO 490.9K
  • POST 549.9K
  • Earning Date
  • BLCO 10-29-2025
  • POST 11-13-2025
  • Dividend Yield
  • BLCO N/A
  • POST N/A
  • EPS Growth
  • BLCO N/A
  • POST 9.69
  • EPS
  • BLCO N/A
  • POST 5.88
  • Revenue
  • BLCO $4,891,000,000.00
  • POST $7,921,200,000.00
  • Revenue This Year
  • BLCO $8.29
  • POST $5.12
  • Revenue Next Year
  • BLCO $5.82
  • POST $8.19
  • P/E Ratio
  • BLCO N/A
  • POST $17.91
  • Revenue Growth
  • BLCO 8.81
  • POST 0.80
  • 52 Week Low
  • BLCO $10.45
  • POST $101.05
  • 52 Week High
  • BLCO $21.08
  • POST $125.84
  • Technical
  • Relative Strength Index (RSI)
  • BLCO 53.23
  • POST 48.84
  • Support Level
  • BLCO $14.67
  • POST $102.94
  • Resistance Level
  • BLCO $15.31
  • POST $108.22
  • Average True Range (ATR)
  • BLCO 0.45
  • POST 2.12
  • MACD
  • BLCO -0.00
  • POST -0.10
  • Stochastic Oscillator
  • BLCO 78.25
  • POST 57.75

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

About POST Post Holdings Inc.

Post Holdings Inc is an consumer packaged goods holding company. It operates in Post Consumer Brands which Includes branded and private label ready-to-eat cereals, Weetabix Includes the businesses of Weetabix Limited, which Post acquired in July 2017 and which produces and distributes branded and private label RTE cereal, hot cereals and other cereal-based food products, Foodservice which Includes egg and potato products in the foodservice and food ingredient channels from the businesses of MFI Holding Corporation, lastly Refrigerated Retail segment Provides refrigerated retail products, inclusive of side dishes, eggs and egg products, sausage, cheese and other dairy and refrigerated products.

Share on Social Networks: